Skip to main content
. Author manuscript; available in PMC: 2022 Nov 19.
Published in final edited form as: Nat Genet. 2022 May 19;54(6):804–816. doi: 10.1038/s41588-022-01069-0

Extended Data Fig. 9.

Extended Data Fig. 9

Immunostaining of PRDM16 protein in coronary atherosclerosis sections. (a) Representative negative control (no primary antibody) immunofluoresence (IF) staining in human coronary artery - left anterior descending (LAD). Positive staining of rabbit anti-PRDM16 in vessels in control kidney tissues. Similar results were observed from n = 4 independent donor samples per tissue. Scale bar = 100 um. (b) Representative IF staining of PRDM16 and LMOD1 in atherosclerotic human coronary artery (LAD) segments from normal-Stage II, Stage III-IV, and Stage V-VI lesions based on Stary classification stages. Red = PRDM16 or LMOD1, Green = alpha smooth muscle actin (a-SMA) and blue = DAPI (nuclei). Scale bar = 1mm (whole slide) or 100 um (highlighted regions of interest). (c) Representative hematoxylin & eosin (H&E) and MOVAT histology staining of distinct human coronary artery segments with similar lesion stages as (b). Scale bar = 1mm. (b-c) Similar results were observed from n = 4 (Normal-stage II), n=6 (Stage III-IV), and n=6 (Stage V-VI) independent donor samples per group.